Related Experiment Video
Updated: Aug 17, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis
Mehrnoosh Tashakori1, Yun Zhang2, Shunbin Xiong2
1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences, Program in Genes and Development.
Unlabelled:
Mdm4 negatively regulates the p53 tumor suppressor. Mdm4 loss in mice leads to an embryonic lethal phenotype that is p53-dependent. Biochemical studies indicate that Mdm4 also binds p73, a member of the p53 family, with higher affinity than p53. In this study, the significance of the Mdm4 and p73 interaction in vivo during embryogenesis and tumorigenesis was examined. The data revealed that p73 loss did not rescue either the early Mdm4-deficient embryonic lethality or the runted phenotype of Mdm4(Δ2/Δ2) p53(+/-) embryos. Furthermore, studies in the developing central nervous system wherein both genes have prominent roles indicated that loss of p73 also did not rescue the Mdm4-null brain phenotype as did p53 loss. This p53 dependency occurred despite evidence for p73-specific transcriptional activity. In tumor studies, the combination of Mdm4 overexpression and p73 loss did not alter survival of mice or the tumor spectrum as compared with Mdm4 overexpression alone. In summary, these data demonstrate that the Mdm4-p73 axis cannot override the dominant role of p53 in development and tumorigenesis.
Implications:
Genetic characterization of the Mdm4 and p73 interaction during development and tumorigenesis suggests new insight into the role of p53 family members, which may influence treatment options for patients.
Insights
The Mdm4-p73 interaction does not significantly impact development or cancer, as p53 plays a dominant role. Loss of p73 did not rescue Mdm4-deficient embryonic lethality or brain abnormalities.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cancer Research
Background:
- Mdm4 is a negative regulator of the p53 tumor suppressor.
- Mdm4 loss causes embryonic lethality dependent on p53.
- Mdm4 binds p73 with higher affinity than p53.
Purpose of the Study:
- To investigate the in vivo significance of the Mdm4-p73 interaction during embryogenesis and tumorigenesis.
Main Methods:
- Genetic analysis of Mdm4 and p73 interactions in mouse models.
- Phenotypic characterization of Mdm4-deficient embryos with varying p73 and p53 genotypes.
- Tumorigenesis studies comparing Mdm4 overexpression with and without p73 loss.
Main Results:
- p73 loss did not rescue Mdm4-deficient embryonic lethality or the runted phenotype in Mdm4(Δ2/Δ2) p53(+/-) embryos.
- Loss of p73 did not rescue the Mdm4-null brain phenotype in the developing central nervous system.
- Overexpression of Mdm4 combined with p73 loss did not alter mouse survival or tumor spectrum compared to Mdm4 overexpression alone.
Conclusions:
- The Mdm4-p73 axis is subordinate to the dominant role of p53 in both development and tumorigenesis.
- Understanding p53 family member roles may inform cancer treatment strategies.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

